Protagenic Therapeutics Stock Price on January 4, 2024
| PTIX Stock | USD 0.50 0.02 3.85% |
Below is the normalized historical share price chart for Protagenic Therapeutics extending back to December 18, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protagenic Therapeutics stands at 0.50, as last reported on the 15th of December 2024, with the highest price reaching 0.54 and the lowest price hitting 0.50 during the day.
If you're considering investing in Protagenic Stock, it is important to understand the factors that can impact its price. Protagenic Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0414, which implies the firm had a -0.0414% return per unit of risk over the last 3 months. Protagenic Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Protagenic Therapeutics' Risk Adjusted Performance of (0.03), variance of 75.25, and Coefficient Of Variation of (1,833) to confirm the risk estimate we provide.
At this time, Protagenic Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 4.6 M in 2024, whereas Common Stock Total Equity is likely to drop 1,132 in 2024. . Price To Sales Ratio is likely to drop to 0.28 in 2024. Price Earnings Ratio is likely to drop to -0.9 in 2024. Protagenic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of January 2016 | 200 Day MA 0.96 | 50 Day MA 0.6348 | Beta 0.25 |
Protagenic |
Sharpe Ratio = -0.0414
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PTIX |
Estimated Market Risk
| 8.67 actual daily | 77 77% of assets are less volatile |
Expected Return
| -0.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Protagenic Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protagenic Therapeutics by adding Protagenic Therapeutics to a well-diversified portfolio.
Price Book 4.6779 | Book Value 0.827 | Enterprise Value -1.5 M | Enterprise Value Ebitda (0.64) | Shares Float 3.3 M |
Related Headline
Aerovate Therapeutics Headline on 4th of January 2024
Acquisition by Santel Donald J of 2889 shares of Aerovate Th... by Santel Donald J
Filed transaction by Aerovate Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Protagenic Therapeutics Valuation on January 4, 2024
It is possible to determine the worth of Protagenic Therapeutics on a given historical date. On January 4, 2024 Protagenic was worth 0.73 at the beginning of the trading date compared to the closed value of 0.96. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Protagenic Therapeutics stock. Still, in general, we apply an absolute valuation method to find Protagenic Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Protagenic Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Protagenic Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.91 | 0.92 | 0.91 | 0.92 | 1,028 | |
01/04/2024 | 0.73 | 1.04 | 0.73 | 0.96 | 2,079 |
| 0.81 | 0.95 | 0.81 | 0.95 | 3,513 |
| Backtest Protagenic Therapeutics | | | Protagenic Therapeutics History | | | Protagenic Therapeutics Valuation | Previous | Next |
Protagenic Therapeutics Trading Date Momentum on January 4, 2024
| On January 05 2024 Protagenic Therapeutics was traded for 0.95 at the closing time. The top price for the day was 0.95 and the lowest listed price was 0.81 . The trading volume for the day was 3.5 K. The trading history from January 5, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.04% . The trading delta at closing time against the current closing price is 9.37% . |
Protagenic Therapeutics Fundamentals Correlations and Trends
By evaluating Protagenic Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Protagenic Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Protagenic financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Protagenic Therapeutics Stock history
Protagenic Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protagenic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protagenic Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protagenic Therapeutics stock prices may prove useful in developing a viable investing in Protagenic Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.3 M | 4.6 M | |
| Net Loss | -4.1 M | -3.9 M |
Protagenic Therapeutics Stock Technical Analysis
Protagenic Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Protagenic Therapeutics Period Price Range
Low | December 15, 2024
| High |
0.00 | 0.00 |
Protagenic Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Protagenic Therapeutics December 15, 2024 Market Strength
Market strength indicators help investors to evaluate how Protagenic Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protagenic Therapeutics shares will generate the highest return on investment. By undertsting and applying Protagenic Therapeutics stock market strength indicators, traders can identify Protagenic Therapeutics entry and exit signals to maximize returns
Protagenic Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protagenic Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protagenic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protagenic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (1.56) | |||
| Treynor Ratio | 0.7604 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.